This article is more than 5 years old. Information may no longer be current.
Carl Zeiss Meditec reports 9.3% increase in revenue for year
Click Here to Manage Email Alerts
Carl Zeiss Meditec pulled in €1,189.9 million in revenue for the 2016/2017 fiscal year, an increase of 9.3% over the previous year’s revenues of €1,088.4 million, according to a company press release.
Earnings per share increased from €1.21 to €1.57.
The company’s ophthalmic devices unit led the company’s strategic business units in growth, garnering revenues of €880.5 million, an increase of 11.2% over the previous fiscal year’s revenues of €791.9 million.
“All segments within this [strategic business unit] achieved growth. The development of refractive lasers, in particular, was very dynamic, as in previous years; however, equipment and consumables for cataract surgery as well as the diagnostics product portfolio also made good contributions to revenue growth,” according to the release.
The microsurgery unit increased from €296.5 million to €309.4 million.
Zeiss’ revenues in the Asia/Pacific region were up from €381.7 million to €448.2 million, while the Americas region revenues increased from €354 million to €378.2 million. The Middle East and African region had an increase of 3% to €363.4 million, and the European region’s revenues remained mostly stable, the release said.